D-dimer level as a risk factor for postoperative venous thromboembolism in Japanese women with gynecologic cancer
Authors:
Open Access
- 3 February 2010
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 21 (8) , 1651-1656
Abstract
Background: The purpose of the present study was to evaluate whether early postoperative D-dimer levels and certain pre-, intra-, and postoperative parameters can be used to predict venous thromboembolism (VTE) in gynecologic cancer patients. Materials and methods: We prospectively evaluated 267 gynecologic cancer patients who underwent surgery at our institution. The plasma D-dimer level was measured serially before the operation and on certain postoperative days. After the operation, primary screening for VTE was undertaken by meticulous examination for clinical signs and elevation of the plasma D-dimer level. Seventy-five patients underwent multidetector row computed tomography and were subjected to further investigations. Results: VTE was detected in 21 of the 75 patients. There were significant differences in the D-dimer value between VTE-positive and VTE-negative patients on postoperative days 3, 5, and 7. The optimal cut-off value for the postoperative D-dimer level was determined as 5 μg/ml on day 3. Logistic regression multivariate analysis revealed that high D-dimer values on postoperative day 3, the use of recombinant human erythropoietin (rHuEPO), and non–O blood group were independent risk factors for postoperative VTE. Conclusion: High plasma D-dimer level on postoperative day 3, the use of rHuEPO, and non–O blood group were independent risk factors for postoperative VTE.Keywords
This publication has 32 references indexed in Scilit:
- Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to ActionJournal of Clinical Oncology, 2009
- Development and validation of a predictive model for chemotherapy-associated thrombosisBlood, 2008
- Venous Thromboembolism and Mortality Associated With Recombinant Erythropoietin and Darbepoetin Administration for the Treatment of Cancer-Associated AnemiaJAMA, 2008
- Extended perioperative thromboprophylaxis in patients with cancerThrombosis and Haemostasis, 2008
- High incidence of silent venous thromboembolism before treatment in ovarian cancerBritish Journal of Cancer, 2007
- ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?Transfusion, 2006
- Usefulness of arterial blood gas analysis and D-dimer measurement in the assessment of pulmonary embolism after orthopedic surgeryJournal of Orthopaedic Science, 2006
- Combined use of clinical pretest probability and D‐dimer test in cancer patients with clinically suspected deep venous thrombosisJournal of Thrombosis and Haemostasis, 2006
- Plasma D‐dimer assays in the diagnosis of venous thromboembolism in cancer patientsJournal of Thrombosis and Haemostasis, 2006
- Preoperative erythropoietin in spine surgeryEuropean Spine Journal, 2004